SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-348733
Filing Date
2017-11-21
Accepted
2017-11-21 08:40:24
Documents
3
Period of Report
2017-11-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d486201d8k.htm 8-K 14259
2 EX-99.1 d486201dex991.htm EX-99.1 13442
3 GRAPHIC g486201g1121015055955.jpg GRAPHIC 2962
  Complete submission text file 0001193125-17-348733.txt   33329
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 171215433
SIC: 8731 Services-Commercial Physical & Biological Research